Responsive Dual-Targeting Exosome as a Drug Carrier for Combination Cancer Immunotherapy
Recently, combination immunotherapy, which incorporates the activation of the immune system and inhibition of immune escape, has been proved to be a new powerful strategy for more efficient tumor suppression compared to monotherapy. However, the major challenge is how to integrate multiple immune dr...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science
2021-01-01
|
| Series: | Research |
| Online Access: | http://dx.doi.org/10.34133/2021/9862876 |